Condition
Chlamydia Infection
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results33% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Terminated2
Completed1
Withdrawn1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00578188WithdrawnPrimary
Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract
NCT01291264TerminatedPrimary
Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM]
NCT00207493Phase 1CompletedPrimary
The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.
NCT00091728TerminatedPrimary
Hormonal Contraception and Risk of Chlamydia and Gonorrhea
Showing all 4 trials